20718 Federal Register / Vol. 73, No.

74 / Wednesday, April 16, 2008 / Notices

Drug Schedule

Oxycodone (9143) ....................................................................................................................................................................................... II

Oxymorphone (9652) ................................................................................................................................................................................... II
Pentobarbital (2270) .................................................................................................................................................................................... II
Phenazocine (9715) .................................................................................................................................................................................... II
Phencyclidine (7471) ................................................................................................................................................................................... II
Phenmetrazine (1631) ................................................................................................................................................................................. II
Phenylacetone (8501) ................................................................................................................................................................................. II
Piminodine (9730) ....................................................................................................................................................................................... II
Powdered opium (9639) .............................................................................................................................................................................. II
Racemethorphan (9732) .............................................................................................................................................................................. II
Racemorphan (9733) ................................................................................................................................................................................... II
Remifentanil (9739) ..................................................................................................................................................................................... II
Secobarbital (2315) ..................................................................................................................................................................................... II
Sufentanil (9740) ......................................................................................................................................................................................... II
Thebaine (9333) .......................................................................................................................................................................................... II

The company plans to import small U.S.C. 958(a); 21 U.S.C. 823(a); and 21 DEA to manufacture such substances,
quantities of the listed controlled CFR 1301.34(b), (c), (d), (e), and (f) are may file comments or objections to the
substances for the National Institute on satisfied. issuance of the proposed registration
Drug Abuse (NIDA) for research Dated: April 9, 2008. pursuant to 21 CFR 1301.33(a).
activities. Joseph T. Rannazzisi, Any such written comments or
Any bulk manufacturer who is objections being sent via regular mail
presently, or is applying to be, Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement should be addressed, in quintuplicate,
registered with DEAto manufacture such Administration. to the Drug Enforcement
basic classes of controlled substances Administration, Office of Diversion
[FR Doc. E8–8177 Filed 4–15–08; 8:45 am]
may file comments or objections to the Control, Federal Register Representative
BILLING CODE 4410–09–P
issuance of the proposed registration (ODL), Washington, DC 20537, or any
and may, at the same time, file a written being sent via express mail should be
request for a hearing on such sent to Drug Enforcement
DEPARTMENT OF JUSTICE
application pursuant to 21 CFR 1301.43 Administration, Office of Diversion
and in such form as prescribed by 21 Drug Enforcement Administration Control, Federal Register Representative
CFR 1316.47. (ODL), 8701 Morrissette Drive,
Any such comments or objections Manufacturer of Controlled Springfield, Virginia 22152; and must be
being sent via regular mail should be Substances; Notice of Application filed no later than June 16, 2008.
addressed, in quintuplicate, to the Drug
Enforcement Administration, Office of Pursuant to § 1301.33(a) of title 21 of Dated: April 9, 2008.
Diversion Control, Federal Register the Code of Federal Regulations (CFR), Joseph T. Rannazzisi,
Representative (ODL), Washington, DC this is notice that on March 14, 2008, Deputy Assistant Administrator, Office of
20537, or any being sent via express Research Triangle Institute, Kenneth H. Diversion Control, Drug Enforcement
mail should be sent to Drug Davis Jr., Hermann Building, East Administration.
Enforcement Administration, Office of Institute Drive, P.O. Box 12194, [FR Doc. E8–8165 Filed 4–15–08; 8:45 am]
Diversion Control, Federal Register Research Triangle, North Carolina BILLING CODE 4410–09–P
Representative (ODL), 8701 Morrissette 27709, made application by renewal to
Drive, Springfield, Virginia 22152; and the Drug Enforcement Administration
must be filed no later than May 16, (DEA) as a bulk manufacturer of the DEPARTMENT OF JUSTICE
2008. basic classes of controlled substances
This procedure is to be conducted listed in schedules I and II: Drug Enforcement Administration
simultaneously with, and independent Manufacturer of Controlled
of, the procedures described in 21 CFR Drug Schedule
Substances; Notice of Application
1301.34(b), (c), (d), (e) and (f). As noted Marihuana (7360) ......................... I
in a previous notice published in the Tetrahydrocannabinols (7370) ...... I Pursuant to § 1301.33(a) of Title 21 of
Federal Register on September 23, 1975, Cocaine (9041) ............................. II the Code of Federal Regulations (CFR),
(40 FR 43745–46), all applicants for this is notice that on March 18, 2008,
registration to import a basic class of The Institute will manufacture small Aldrich Chemical Company Inc., DBA
any controlled substances in schedule I quantities of cocaine and marihuana Isotec, 3858 Benner Road, Miamisburg,
or II are and will continue to be required derivatives for use by their customers in Ohio 45342–4304, made application by
to demonstrate to the Deputy Assistant analytical kits, reagents, and reference renewal to the Drug Enforcement
Administrator, Office of Diversion standards as directed by the National Administration (DEA) as a bulk
Control, Drug Enforcement Institute on Drug Abuse. manufacturer of the basic classes of
Administration, that the requirements Any other such applicant, and any controlled substances listed in
for such registration pursuant to 21 person who is presently registered with schedules I and II:
jlentini on PROD1PC65 with NOTICES

Drug Schedule

Cathinone (1235) ......................................................................................................................................................................................... I

Methcathinone (1237) .................................................................................................................................................................................. I
N-Ethylamphetamine (1475) ........................................................................................................................................................................ I

VerDate Aug<31>2005 19:08 Apr 15, 2008 Jkt 214001 PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 E:\FR\FM\16APN1.SGM 16APN1
 Federal Register / Vol. 73, No. 74 / Wednesday, April 16, 2008 / Notices 20719

Drug Schedule

N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I

Aminorex (1585) .......................................................................................................................................................................................... I
Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... I
Methaqualone (2565) .................................................................................................................................................................................. I
Ibogaine (7260) ........................................................................................................................................................................................... I
Lysergic acid diethylamide (7315) ............................................................................................................................................................... I
Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I
Mescaline (7381) ......................................................................................................................................................................................... I
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I
3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I
4-Methoxyamphetamine (7411) ................................................................................................................................................................... I
Psilocybin (7437) ......................................................................................................................................................................................... I
Psilocyn (7438) ............................................................................................................................................................................................ I
N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... I
Dihydromorphine (9145) .............................................................................................................................................................................. I
Normorphine (9313) .................................................................................................................................................................................... I
Acetylmethadol (9601) ................................................................................................................................................................................. I
Alphacetylmethadol except levo-alphacetylmethadol (9603) ...................................................................................................................... I
Normethadone (9635) ................................................................................................................................................................................. I
Norpipanone (9636) ..................................................................................................................................................................................... I
3-Methylfentanyl (9813) ............................................................................................................................................................................... I
Amphetamine (1100) ................................................................................................................................................................................... II
Methamphetamine (1105) ........................................................................................................................................................................... II
Methylphenidate (1724) ............................................................................................................................................................................... II
Amobarbital (2125) ...................................................................................................................................................................................... II
Pentobarbital (2270) .................................................................................................................................................................................... II
Secobarbital (2315) ..................................................................................................................................................................................... II
1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II
Phencyclidine (7471) ................................................................................................................................................................................... II
Phenylacetone (8501) ................................................................................................................................................................................. II
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ II
Cocaine (9041) ............................................................................................................................................................................................ II
Codeine (9050) ............................................................................................................................................................................................ II
Dihydrocodeine (9120) ................................................................................................................................................................................ II
Oxycodone (9143) ....................................................................................................................................................................................... II
Hydromorphone (9150) ............................................................................................................................................................................... II
Benzoylecgonine (9180) .............................................................................................................................................................................. II
Ethylmorphine (9190) .................................................................................................................................................................................. II
Hydrocodone (9193) .................................................................................................................................................................................... II
Isomethadone (9226) .................................................................................................................................................................................. II
Meperidine (9230) ....................................................................................................................................................................................... II
Meperidine Intermediate—A (9232) ............................................................................................................................................................ II
Meperidine Intermediate—B (9233) ............................................................................................................................................................ II
Methadone (9250) ....................................................................................................................................................................................... II
Methadone Intermediate (9254) .................................................................................................................................................................. II
Dextropropoxyphene, bulk, (non-dosage forms) (9273) ............................................................................................................................. II
Morphine (9300) .......................................................................................................................................................................................... II
Thebaine (9333) .......................................................................................................................................................................................... II
Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II
Oxymorphone (9652) ................................................................................................................................................................................... II
Fentanyl (9801) ........................................................................................................................................................................................... II

The company plans to manufacture (ODL), Washington, DC 20537, or any DEPARTMENT OF JUSTICE
small quantities of the listed controlled being sent via express mail should be
substances to produce isotope labeled sent to Drug Enforcement Drug Enforcement Administration
standards for drug testing and analysis. Administration, Office of Diversion
Any other such applicant, and any Control, Federal Register Representative Manufacturer of Controlled
person who is presently registered with (ODL), 8701 Morrissette Drive, Substances; Notice of Registration
DEA to manufacture such substances, Springfield, Virginia 22152; and must be
may file comments or objections to the By Notice dated November 5, 2007
filed no later than June 16, 2008.
issuance of the proposed registration and published in the Federal Register
Dated: April 9, 2008. on November 16, 2007 (72 FR 64681),
pursuant to 21 CFR 1301.33(a).
Any such written comments or Joseph T. Rannazzisi, JFC Technologies, LLC., 100 W. Main
jlentini on PROD1PC65 with NOTICES

objections being sent via regular mail Deputy Assistant Administrator, Office of Street, Bound Brook, New Jersey 08805,
should be addressed, in quintuplicate, Diversion Control, Drug Enforcement made application by renewal to the
to the Drug Enforcement Administration. Drug Enforcement Administration
Administration, Office of Diversion [FR Doc. E8–8176 Filed 4–15–08; 8:45 am] (DEA) to be registered as a bulk
Control, Federal Register Representative BILLING CODE 4410–09–P manufacturer of Diphenoxylate (9170), a

VerDate Aug<31>2005 17:19 Apr 15, 2008 Jkt 214001 PO 00000 Frm 00112 Fmt 4703 Sfmt 4703 E:\FR\FM\16APN1.SGM 16APN1